| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8222046 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 7 Pages |
Abstract
Pharmacokinetic modeling of MRI contrast-enhancement curves evidenced significant alterations in parameters associated with increased tumor vessel permeability and tumor perfusion after 227Th-trastuzumab treatment of HER2-expressing ovarian cancer xenografts.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Helen MSc, Kathrine PhD, Ellen Mengshoel PhD, Jostein PhD,